 HOUSTON, Feb. 16, 2021 GLOBE NEWSWIRE -- Salarius Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that it will participate in the BIO CEO Investor Digital Conference taking place Tuesday, February 16, 2021 to Thursday, February 18, 2021. 